Modeling in the Pharmaceutical Industry II

Thursday, November 20, 2008: 12:30 PM
307-A (Pennsylvania Convention Center)

Description:
The development of pharmaceuticals involves the development of both process and chemistry/formulation to produce the active pharmaceutical ingredient/final drug product. We invite contributions from industry and academia that address system-level process simulation (cycle time analysis, mass and energy balances, equipment usage, scheduling etc.) and/or more detailed unit operations modeling during process development and scale-up in pharmaceutical synthesis and formulation (e.g. reaction steps, kinetics, solvent chasing, crystallization, filtration, drying). Particular consideration will be given to examples of model development from laboratory data with model validation during scale-up and clear savings or greater process understanding as a result of process modeling.


Sponsor:
Pharmaceuticals


Chair:
Richard Schild
Email: richard.schild@bms.com

CoChair:
Christopher L. Burcham
Email: cburcham@lilly.com


12:30 PM
(651a) Application of Quality by Design Principles In the Model Predictions for Scale-up of Tablet Film Coating
Andrew Prpich, Mary T. Am Ende, Thomas Katzschner, Veronica Lubczyk, Holger Weyhers and Georg Bernhard

12:50 PM

1:10 PM
(651c) Use of Pharmacokinetic/pharmacodynamic (PK/PD) Modeling to Aid Formulation Selection
Larissa A. Wenning, Eseng Lai, Tami Crumley, Tian-Quan Cai, Fang Liu, M. G. Waters, Shaun Fitzpatrick and Julie Stone

1:50 PM

2:20 PM
(651f) Finite Element Analysis of Tablet Compaction Using a Modified Material Plasticity Model
Tuhin Sinha, Jennifer S. Curtis, Bruno C. Hancock and Carl R. Wassgren
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division